AFF4 (AF4/FMR2), as a core component of the super elongation complex [25], is involved in the progression of cancer, e.g., leukemia [26], head and neck squamous cell carcinoma [27], melanoma [28], bladder cancer [29, 30], and lung cancer [31]. Here, AFF4 is linked to urinary bladder cancer.